Template-assisted fabrication of protein nanocapsules
Source abstract
Abstract
Bionanomaterials have recently begun to spark a great amount of interest and could potentially revolutionize biomedical research. Nanoparticles, nanocapsules, and nanotubular structures are becoming attractive options in drug and gene delivery. The size of the delivery vehicles greatly impacts cellular uptake and makes it highly desirable to precisely control the diameter and length of nanocarriers to make uniform nanoparticles at low cost. Carbon nanotubes have shown great potential within the field of drug and gene delivery. However, their insolubility and cytotoxicity could severely delay FDA approval. A desirable alternative would be to fabricate nanostructures from biomaterials such as proteins, peptides, or liposomes, which are already FDA approved. In this article we demonstrate the preparation of protein nanocapsules with both ends sealed using a template-assisted alternate immersion method combined with controlled cleaving. Glucose oxidase nanocapsules with controllable diameter, wall thickness, and length were fabricated and characterized with SEM and TEM. The biochemical activity of glucose oxidase in the form of nanocapsules after processing was confirmed using UV spectrometry. Our future work will explore proteins suitable for drug encapsulation and cellular uptake and will focus on optimizing the cleaving process to gain precise control over the length of the nanocapsules.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Supramolecular Self-Assembly in Materials · RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (37)
Show source-provided references
1. Audette GF, van Schaik EJ, Hazes B et al (2004) DNA-binding protein nanotubes: learning from nature’s nanotech examples. Nano Lett 4:1897–190210.1021/nl048942f ↗
2. Baker LA, Jin P, Martin CR (2005) Biomaterials and biotechnologies based on nanotube membranes. Crit Rev Solid State Mater Sci 30:183–20510.1080/10408430500198169 ↗
3. Bianco A, Prato M (2003) Can carbon nanotubes be considered useful tools for biological applications? Adv Mater 15:1765–176810.1002/adma.200301646 ↗
4. Bianco A, Kostarelos K, Prato M (2005) Applications of carbon nanotubes in drug delivery. Curr Opin Chem Biol 9:674–67910.1016/j.cbpa.2005.10.005 ↗
5. Chen JF, Ding HM, Wang JX et al (2004) Preparation and characterization of porous hollow silica nanoparticles for drug delivery application. Biomaterials 25:723–72710.1016/S0142-9612(03)00566-0 ↗
6. Couet J, Biesalski M (2006) Surface-initiated ATRP of N-isopropylacrylamide from initiator-modified self-assembled peptide nanotubes. Macromolecules 39:7258–726810.1021/ma061200j ↗
7. Courvreur P, Gref R, Andrieux K et al (2006) Nanotechnologies for drug delivery: Application to cancer and autoimmune diseases. Prog Solid State Chem 34:231–23510.1016/j.progsolidstchem.2005.11.009 ↗
8. Cui D, Tian F, Ozkan CS et al (2005) Effect of single walled carbon nanotubes on human HEK293 cells. Toxicol Lett 155:73–8510.1016/j.toxlet.2004.08.015 ↗
9. Decuzzi P, Ferrari M (2007) The role of specific and non-specific interactions in receptor-mediated endocytosis of nanoparticles. Biomaterials 28:2915–292210.1016/j.biomaterials.2007.02.013 ↗
10. Fifis T, Gamvrellis A, Crimeen-Irwin B et al (2004) Size-dependent immunogenicity: Therapeutic and protective properties of nano-vaccines against Tumors. J Immunol 173:3148–315410.4049/jimmunol.173.5.3148 ↗
11. Gao H, Shi W, Freund LB (2005) Mechanics of receptor-mediated endocytosis. Proc Natl Acad Sci U.S.A 102:9469–947410.1073/pnas.0503879102 ↗
12. Gao L, Nie L, Wang T et al (2006) Carbon nanotube delivery of the GFP Gene into mammalian cells. ChemBioChem 7:239–24210.1002/cbic.200500227 ↗
13. Ghadiri MR, Granja JR, Milligan RA et al (1993) Self-assembling organic nanotubes based on a cyclic peptide architecture. Nature 366:324–32710.1038/366324a0 ↗
14. Harashima H, Sakata K, Funato K et al (1994) Enhanced hepatic uptake of liposomes through complement activation depending on the size of liposomes. Pharm Res 11:402–40610.1023/A:1018965121222 ↗
15. Hou S, Wang J, Martin CR (2005) Template-synthesized protein nanotubes. Nano Lett 5:231–23410.1021/nl048305p ↗
16. Kakizawa Y, Furukawa S, Ishii A et al (2006) Organic-inorganic hybrid-nanocarrier of siRNA constructing through the self-assembly of calcium phosphate and PEG based block anomer. J Control Release 111:368–37010.1016/j.jconrel.2006.01.004 ↗
17. Klumpp C, Kostarelos K, Prato M et al (2006) Functionalized carbon nanotubes as emerging nanovectors for the delivery of therapeutics. Biochim Biophys Acta 1758:404–41210.1016/j.bbamem.2005.10.008 ↗
18. Kol N, Adler-Abramovich L, Barlam D et al (2005) Self-assembled peptide nanotubes are uniquely rigid bioinspired supramolecular structures. Nano Lett 5:1343–134610.1021/nl0505896 ↗
19. Langer K, Balthasar S, Vogel V et al (2003) Optimization of the preparation process for human serum albumin (HSA) nanoparticles. Int J Pharm 257:169–18010.1016/S0378-5173(03)00134-0 ↗
20. Liang J, Chik H, Yin A et al (2002) Two-dimensional lateral superlattices of nanostructures: Nonlithographic formation by anodic membrane template. J Appl Phys 91:2544–254610.1063/1.1433173 ↗
21. Lu G, Ai S, Li J (2005) Layer-by-layer assembly of human serum albumin and phospholipids nanotubes based on a template. Langmuir 21:1679–168210.1021/la047771r ↗
22. Martin CR, Kohli P (2003) The emerging field of nanotube biotechnology. Nat Rev Drug Discov 2:29–3710.1038/nrd988 ↗
23. Matsumura S, Uemura S, Mihara H (2005) Construction of biotinylated peptide nanotubes for arranging proteins. Mol Biosyst 1:146–14810.1039/b504516a ↗
24. McKenzie JL, Waid MC, Shi R et al (2003) Decreased functions of astrocytes on carbon nanofiber materials. Biomaterials 25:1309–131710.1016/j.biomaterials.2003.08.006 ↗
25. Neuberger T, Schopf B, Hofmann H et al (2005) Superparamagnetic nanoparticles for biomedical applications: possibilities and limitations of a new drug delivery system. J Magn Magn Mater 293:483–49610.1016/j.jmmm.2005.01.064 ↗
26. Nishiyama N, Kataoka K (2006) Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. Pharmacol Ther 112:630–64810.1016/j.pharmthera.2006.05.006 ↗
27. Panarotto D, Briand J, Prato M et al (2004a) Translocation of bioactive peptides across cell membranes by carbon nanotubes. Chem Commun 1:16–1710.1039/b311254c ↗
28. Pantarotto D, Singh R, McCarthy D et al (2004b) Functionalized carbon nanotubes for plasmid DNA gene delivery. Angew Chem Int Ed 43:5242–524610.1002/anie.200460437 ↗
29. Park KH, Chhowalla M, Iqbal Z et al (2003) Single-walled carbon nanotubes are a new class of ion channel blockers. J Biol Chem 278:50212–5021610.1074/jbc.M310216200 ↗
30. Putnam D (2006) Polymers for gene delivery across length scales. Nat Mater 5:439–45110.1038/nmat1645 ↗
31. Shi Kam NW, Dai H (2005) Carbon nanotubes as intracellular protein transporters: Generality and biological functionality. J Am Chem Soc 127:6021–502610.1021/ja050062v ↗
32. Shvedova A, Castranova V, Kisin E et al (2003) Exposure to carbon nanotube material: Assessment of carbon nanotube cytotixicity using human keratinocyte cells. J Toxicol Environ Health A 66:1909–192610.1080/713853956 ↗
33. Spector MS, Selinger JV, Singh A et al (1998) Controlling the morphology of chiral lipid tubules. Langmuir 14:3493–350010.1021/la980086y ↗
34. Syte S, Kumon Y, Ishigaki A (1998) Immobilization of glucose oxidase on poly-(L-lysine)-modified polycarbonate membrane. Biotechnol Appl Biochem 27:245–24810.1111/j.1470-8744.1998.tb00501.x ↗
35. Tian Y, He Q, Cui Y et al (2006) Fabrication of protein nanotubes based on layer-by-layer assembly. Biomacromolecules 7:2539–254210.1021/bm060412l ↗
36. Win KY, Feng SS (2005) Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials 26:2713–272210.1016/j.biomaterials.2004.07.050 ↗
37. Xu ZP, Zeng QH, Lu GQ et al (2006) Inorganic nanoparticles as carriers for efficient cellular delivery. Chem Eng Sci 61:1027–104010.1016/j.ces.2005.06.019 ↗